bromocriptine has been researched along with Invasiveness, Neoplasm in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (34.78) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 7 (30.43) | 29.6817 |
2010's | 1 (4.35) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
Authors | Studies |
---|---|
Oearsakul, T; Taweesomboonyat, C | 1 |
Chen, Y; Fang, Q; Gao, H; Gui, S; Guo, J; Li, C; Liu, C; Wang, J; Wang, Z; Xie, W; Zhang, Y; Zhao, P; Zhu, H | 1 |
Huang, HY; Hui, GZ; Tang, H; Wu, ZB; Zhai, W | 1 |
Ho, WL; Shen, CC; Yang, MY | 1 |
Delgrange, E; Jan, M; Perrin, G; Sassolas, G; Trouillas, J | 1 |
Gong, J; Wu, Z; Yu, C | 1 |
Su, ZP; Wu, JS; Wu, ZB; Zheng, WM; Zhong, M; Zhuge, QC | 1 |
Chang, RJ; Goodman, LA | 1 |
Coca, JM; Díaz de Tuesta, JI; Izquierdo, JM; San Emeterio, F | 1 |
Alfonso Collado, JI; Domínguez Ugidos, LJ; Martínez Subías, J; Sancho Serrano, E; Urpegui García, A; Vallés Varela, H | 1 |
Acikgoz, B; Oruckaptan, HH; Ozcan, OE; Ozgen, T | 1 |
Oruçkaptan, HH; Ozcan, OE; Ozgen, T; Senmevsim, O | 1 |
Delgrange, E; Donckier, J; Guigard, MP; Jan, M; Jouanneau, E; Maiter, D; Perrin, G; Tourniaire, J; Trouillas, J | 1 |
Horvath, E; Kovacs, K; Kuroki, T; Lloyd, RV; Scheithauer, BW; Vidal, S | 1 |
Cook, DB; Hall, K; Hall, R; McGregor, AM; Scanlon, MF | 1 |
MacFarlane, IA; MacKenzie, JM; Petterson, T; Shaw, MD | 1 |
Delahunt, JW; Feek, CM; Grebe, SK | 1 |
Davis, JR; Heath, DA; Sheppard, MC | 1 |
Bevan, JS; Hourihan, M; Peters, JR; Roberts, A; Sussman, J | 1 |
Besser, M; Cook, RJ | 1 |
Flanigan, S; Jordan, RM; Kohler, PO; Murphy, FY; Vesely, DL | 1 |
Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD | 1 |
De Gennes, JL; Heshmati, HM; Metzger, J; Schaison-Cusin, M; Scherrer, H; Thibierge, M; Turpin, G | 1 |
3 review(s) available for bromocriptine and Invasiveness, Neoplasm
Article | Year |
---|---|
[Invasive giant prolactinoma].
Topics: Adult; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Skull Base Neoplasms | 1998 |
Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature.
Topics: Bromocriptine; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Hypophysectomy; Injections, Intralesional; Neoplasm Invasiveness; Pituitary Irradiation; Pituitary Neoplasms; Prolactinoma; Radiotherapy, Adjuvant; Treatment Outcome | 1999 |
Pituitary adenomas: results of 684 surgically treated patients and review of the literature.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Hormones, Ectopic; Humans; Hypophysectomy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2000 |
20 other study(ies) available for bromocriptine and Invasiveness, Neoplasm
Article | Year |
---|---|
Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Topics: Acromegaly; Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Chemotherapy, Adjuvant; Female; Growth Hormone-Secreting Pituitary Adenoma; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; Logistic Models; Male; Microsurgery; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neuroendoscopy; Neurosurgical Procedures; Pituitary Neoplasms; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Reoperation; Retrospective Studies; Sex Factors; Sphenoid Sinus; Treatment Failure; Treatment Outcome; Tumor Burden | 2021 |
Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
Topics: Adenoma; Adult; Aged; Bromocriptine; Cell Proliferation; DNA Copy Number Variations; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Middle Aged; Neoplasm Invasiveness; Oncogene Proteins v-erbB; Organelle Biogenesis; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Proto-Oncogene Proteins c-myc; Ribosomes; RNA-Seq; Signal Transduction; TOR Serine-Threonine Kinases; Transaminases; Whole Genome Sequencing; Young Adult | 2020 |
Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult | 2018 |
Treatments of multi-invasive giant prolactinoma.
Topics: Aged; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron, Transmission; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy | 2004 |
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Topics: Adult; Aged; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Hypophysectomy; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitotic Index; Neoplasm Invasiveness; Neoplasm Staging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sex Factors | 2005 |
Combined treatment of invasive giant prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Craniotomy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 2005 |
Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cavernous Sinus; Chemotherapy, Adjuvant; Dopamine Agonists; Empty Sella Syndrome; Female; Follow-Up Studies; Hernia; Humans; Magnetic Resonance Imaging; Male; Microsurgery; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Optic Chiasm; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2008 |
Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Hormones; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Sella Turcica; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1984 |
[Effect of treatment with bromocriptine in prolactinomas without surgical intervention].
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1983 |
[Prolactinoma in man: clinical and histological characteristics].
Topics: Adolescent; Adult; Bromocriptine; Cell Division; Drug Resistance; Female; Hormone Antagonists; Humans; Ki-67 Antigen; Male; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Proliferating Cell Nuclear Antigen; Retrospective Studies; Sex Characteristics | 2000 |
Microvessel density in pituitary adenomas and carcinomas.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Antigens, Nuclear; Bromocriptine; Carcinoma; Child; Dopamine Agonists; Female; Hormones; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Microcirculation; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Octreotide; Pituitary Neoplasms | 2001 |
Reduction in size of a pituitary tumor by bromocriptine therapy.
Topics: Adenoma; Adult; Bromocriptine; Humans; Male; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1979 |
Prolactin secreting pituitary carcinoma.
Topics: Adult; Brain; Bromocriptine; Combined Modality Therapy; Humans; Hypophysectomy; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Treatment of extensively invasive (giant) prolactinomas with bromocriptine.
Topics: Adult; Bromocriptine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma | 1992 |
Giant invasive prolactinoma: a case report and review of nine further cases.
Topics: Adult; Aged; Bromocriptine; Dopamine; Female; Humans; Jugular Veins; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; RNA, Messenger; Tumor Cells, Cultured | 1990 |
Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report.
Topics: Adult; Bromocriptine; Estrogen Replacement Therapy; Female; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma | 1989 |
A 16 year old boy with poor vision and nasal obstruction.
Topics: Adenoma; Adolescent; Bromocriptine; Combined Modality Therapy; Humans; Male; Neoplasm Invasiveness; Nose Diseases; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Vision Disorders; Visual Fields | 1987 |
Giant invasive prolactinomas.
Topics: Adult; Bromocriptine; Cobalt Radioisotopes; Combined Modality Therapy; Ear, Inner; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paranasal Sinuses; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1987 |
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin | 1985 |
[Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Time Factors | 1985 |